Preclinical evaluation of leflunomide repositioning for the management of chronic chikungunya arthritis

Vol. 1 2024 - 347433
E-poster
Favoritar este trabalho
Como citar esse trabalho?
Resumo

Chikungunya virus (CHIKV) infection frequently causes chronic joint pain lasting months to years after the acute phase, significantly impairing patients' quality of life. Current therapies are largely symptomatic, with limited efficacy in chronic cases. Evidence indicates that persistent arthralgia is driven by a sustained articular inflammatory microenvironment involving T-lymphocyte infiltration and pro-inflammatory cytokine production. Leflunomide (LEF), an immunomodulatory drug widely used in rheumatoid arthritis, inhibits T-cell proliferation and modulates pro-inflammatory cytokines, including interferon-gamma, supporting its potential repurposing for CHIKV-induced chronic arthritis. This project aims to evaluate the effect of LEF on CHIKV-induced chronic pain and joint inflammation in mice following intra-articular viral injection. Female Swiss mice (8–10 weeks old) were infected intra-articularly with CHIKV (10⁶ PFU/site) and treated with LEF (10 mg/kg, p.o., 5x/week for 3 weeks), starting 14 days post-infection. Knee edema was measured with a digital caliper, mechanical allodynia via von Frey filaments, and pain-related behavior during knee flexion using an adapted electronic von Frey device (CEUA/UFRJ: A19/24-008-21). CHIKV infection did not induce detectable knee edema but caused mechanical allodynia and increased sensitivity to knee flexion. Both pain responses were significantly reversed by LEF treatment. These findings provide preclinical evidence supporting LEF as a therapeutic option for chronic CHIKV-induced joint pain. Given its current use in Brazil's public health system (SUS), these results highlight its high translational potential for clinical application.

References: 

  • J. Glob. Infect. Dis. (2023) 15:131–132.
  • Clin. Immunol. (1999) 93:198–208.

Compartilhe suas ideias ou dúvidas com os autores!

Sabia que o maior estímulo no desenvolvimento científico e cultural é a curiosidade? Deixe seus questionamentos ou sugestões para o autor!

Faça login para interagir

Tem uma dúvida ou sugestão? Compartilhe seu feedback com os autores!

Instituições
  • 1 Federal University of Rio de Janeiro
  • 2 Universidade Federal do Rio de Janeiro (UFRJ)
  • 3 Federal University of Rio de Janeiro (UFRJ)
Eixo Temático
  • Neuroinflammation
Palavras-chave
Chikungunya virus
Leflunomide
Chronic pain
Mechanical allodynia
Joint inflammation